Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VisionApp - Refraction and Presbyopia

NCT: NCT07570602 · COMPLETED

NCT IDNCT07570602
StatusCOMPLETED
Start Date2023-07-05
Completion2023-07-24

Brief Summary

Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to refraction and presbyopia. VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Frequently Asked Questions

What is VisionApp - Refraction and Presbyopia?

VisionApp - Refraction and Presbyopia is a clinical trial registered under NCT07570602. Current status: COMPLETED.

What is the status of NCT07570602?

The current status of NCT07570602 (VisionApp - Refraction and Presbyopia) is: COMPLETED.

When did VisionApp - Refraction and Presbyopia start?

VisionApp - Refraction and Presbyopia started on 2023-07-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.